central nervous system

(redirected from Central nervous system diseases)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for central nervous system

References in periodicals archive ?
Mitsubishi Pharma Corporation is a global research-driven pharmaceutical company targeting the therapeutic areas of cardiovascular and metabolic diseases, psychiatric and central nervous system diseases, immunological and respiratory diseases, and cancer and hepatic disease.
The nonprofit group sends medical professionals to developing nations to train local physicians to treat children born with central nervous system diseases.
Overall, this is a good, practical guide to differential diagnosis of central nervous system diseases encountered in the neurosurgery-surgical pathology area, and it is particularly handy for practicing pathologists in community hospitals.
To date, Millennium has delivered three novel genes implicated in central nervous system diseases to Wyeth-Ayerst, all resulting in milestone payments to Millennium.
Through its activity on the mast cell and certain kinases essential to the activation of the inflammatory cells and fibrosing tissue remodeling, masitinib can have an effect on the symptoms associated with some inflammatory and central nervous system diseases.
The company's management team includes globally recognized specialists in central nervous system diseases and drug development, who together leverage the latest scientific knowledge and understanding of neurological disorders.
Solvay Pharmaceuticals Conference on Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases (8th: 2007: Nice, France).
It s core therapeutic areas are psychiatric and central nervous system diseases, cardiovascular and metabolic diseases, immunological and respiratory diseases, and cancer and hepatic diseases.
com/research/e037d9/drug_delivery_in_c) has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies" to their extensive offering of pharmaceutical market research publications.
com/research/r6wspz/drug_delivery_in) has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies" to their offering.
The company is a global research-driven pharmaceutical company targeting the therapeutic areas of psychiatric and central nervous system diseases, cardiovascular and metabolic diseases, immunological and respiratory diseases, and cancer and hepatic disease.
LONDON -- In recent years there has been an increase in the quantity of clinical trials conducted on central nervous system diseases, according to a new report available on companiesandmarkets.
Full browser ?